Federal lawmakers expressed surprise at the lack of regulatory oversight over medical uses of radiation at hearings in the U.S. Congress today. While everyone in attendance agreed that the current regulatory environment needs fixing, the thorny question is how to go about doing it.
Congress surprised at lack of medical radiation oversight
Feb 25, 2010
Latest in Radiation Oncology/Therapy
Elekta secures U.S. FDA 510(k) clearance for Evo
January 16, 2026
ASTRO introduces new research foundation approach
January 2, 2026



















